Search

Ruxolitinib cream for non-segmental vitiligo in people 12+

NICE has published updated technology appraisal guidance (TA1140) on ruxolitinib cream for treating non-segmental vitiligo in individuals aged 12 and over. This guidance replaces previous recommendations and includes information on commercial arrangements for the drug.

Nivolumab for Urothelial Cancer Appraisal Terminated

NICE has terminated the appraisal of nivolumab for urothelial cancer because the company failed to submit evidence. The guidance will be reviewed if the company decides to make a submission in the future.

Health Commissioner Statement on Court Ruling and Vaccine Science

New York State Health Commissioner Dr. James McDonald issued a statement on a federal judge's ruling concerning the Advisory Committee on Immunization Practices (ACIP). The statement reaffirms the department's commitment to vaccine science and protection against preventable diseases.

MHRA Field Safety Notices for Medical Devices

The MHRA has published a list of Field Safety Notices (FSNs) for medical devices issued between March 9-13, 2026. These notices are for informational purposes, and recipients are advised to act on any FSN received from a manufacturer.

MHRA NICE Integrated Scientific Advice Service Guidance

The MHRA and NICE have updated guidance on their Integrated Scientific Advice (ISA) service for medicine developers. The updates provide additional information on preparing for ISA meetings, including specific guidance on writing questions, creating briefing books, and understanding ISA reports and fees.

VA Health Districts Partner with Jail to Improve Inmate Health Literacy

The Virginia Department of Health's Hampton & Peninsula Health Districts have partnered with the Virginia Peninsula Regional Jail to offer an eight-week health literacy program to incarcerated individuals. This initiative aims to reduce health disparities and improve health outcomes for those re-entering the community.

Virginia Health Department Closures and Early Closures

The Virginia Department of Health announced closures and early closures for various health departments and clinics on Monday, March 16, 2026. This notice details specific facilities and their operational status for the day.

EMA CHMP Agenda: Hetlioz for Smith-Magenis Syndrome

The European Medicines Agency (EMA) has published the agenda for an extraordinary CHMP meeting on March 16, 2026. The agenda includes discussions on the re-examination procedure for Hetlioz (Tasimelteon) for Smith-Magenis Syndrome, involving oral explanations and variations to marketing authorisations.

COVID-19 Vaccines: Safety Profile Confirmed

The French National Agency for the Safety of Medicines and Health Products (ANSM) has confirmed the safety profile of COVID-19 vaccines. The agency stated that no new safety signals have been identified, reinforcing the established safety of these vaccines.

FDA Meeting on State Drug Importation Program

The FDA held a meeting with several states to discuss the Section 804 Importation Program (SIP), which allows states to import certain prescription drugs from Canada. This meeting is part of the FDA's implementation of an executive order aimed at lowering drug prices for American consumers.